Literature DB >> 23001713

CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis.

Giulia Pazzola1, Luigi Boiardi, Bruno Casali, Enrico Farnetti, Davide Nicoli, Nicolò Pipitone, Ilaria Padovano, Andrea Caruso, Mariagrazia Catanoso, Carlo Salvarani.   

Abstract

OBJECTIVES: To evaluate the potential role of CC chemokine receptor 5 (CCR5)Δ32 polymorphism in the susceptibility to giant cell arteritis (GCA) in a cohort of Italian patients.
METHODS: 176 consecutive Italian patients with biopsy-proven GCA and 180 healthy age- and sex-matched blood donors were molecularly genotyped for the CCR5Δ32 polymorphism.
RESULTS: No statistically significant difference in the Δ32CCR5 allele frequency between GCA patients (5.1 %) and controls (2.8 %) was observed (p = 0.109). Carriers of the CCR5Δ32 allele (Δ32/Δ32 + CCR5/Δ32) were similarly represented in the two groups.
CONCLUSIONS: Our results do not support a role for the CCR5Δ32 polymorphism in determining susceptibility to GCA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001713     DOI: 10.1007/s10165-012-0751-5

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  2 in total

1.  Frequency of CCR5Δ32 allele in healthy Bosniak population.

Authors:  Grażyna Adler; Amina Valjevac; Karolina Skonieczna-Żydecka; Mirela Mackic-Djurovic; Miłosz Parczewski; Anna Urbańska; Nermin Nusret Salkic
Journal:  Bosn J Basic Med Sci       Date:  2014-08-28       Impact factor: 3.363

2.  Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.

Authors:  Y H Lee; J-H Kim; G G Song
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.